Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy

International Journal of Cardiology

Volumn 112, Issue 3, 2006, Pages 275-281

  Tingberg, Erik ^a   Öhlin, Ann Kristin ^a   Gottsäter, Anders ^a   Öhlin, Hans ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Heart failure; Isoprostanes; Lipid peroxidation; Malondialdehyde; Nitrates; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; ISOPROSTANE DERIVATIVE; ISOSORBIDE 5 NITRATE; LOSARTAN; MALONALDEHYDE; METOPROLOL; NATRIURETIC FACTOR; NITRATE; PLACEBO; RAMIPRIL; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HUMAN; LIPID PEROXIDATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; COMORBIDITY; DELAYED-ACTION PREPARATIONS; DINOPROST; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; ISOSORBIDE DINITRATE; LIPID PEROXIDATION; LOSARTAN; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE DONORS; OXIDATIVE STRESS; RAMIPRIL; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33748800720     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.09.004     Document Type: Article

References (34)

1. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 1352-1356
2. Singal P.K., and Kirshenbaum L.A. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 6 (1990) 47-49
3. Passad K., and Kalra J. Oxygen free radicals and heart failure. Angiology 39 (1988) 417-420
4. McMurray J., McLay J., Chopra M., Bridges A., and Bewich J.J.F. Evidence for free radical activity in chronic heart failure secondary to coronary artery disease. Am J Cardiol 65 (1990) 1261-1262
5. Diaz-Velez C.R., Garcia-Castineiras S., Mendoza-Ramos E., and Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 31 (1996) 1352-1356
6. Sobotka P.A., Brottman M.D., Weitz Z., Birnbaum A.J., Skosey J.L., and Zarling E.J. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med 14 6 (1993) 643-647
7. Cracowski J.L., Tremel F., Marpeau C., et al. Increased formation of F(2)-isoprostanes in patients with severe heart failure. Heart 84 4 (2000) 439-440
8. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., and Tedgui A. Elevated levels of 8-iso-prostaglandin F2 alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97 16 (1998) 1536-1539
9. Hill M.F., and Singal P.K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96 7 (1997) 2414-2420
10. Dhalla A.K., Hill M.F., and Singal P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28 2 (1996) 506-514
11. Cohn J.N. Nitrates for congestive heart failure. Am J Cardiol 56 (1985) 19A-23A
12. Bassenge E., and Stewart D.J. Effects of nitrates in various vascular sections and regions. Z Kardiol 75 (1986) 1-7
13. Jessup W., Mohr D., Gieseg S.P., Dean R.T., and Stocker R. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta 1180 1 (1992) 73-82
14. Padmaja S., and Huie R.E. The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun 195 (1993) 539-544
15. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87 (1990) 1620-1624
16. Hogg N., Darley-Usmar V.M., Wilson M.T., and Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281 (1992) 419-424
17. Tingberg E., Roijer A., Thilen U., Eskilsson J., and Öhlin H. Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction following acute myocardial infarction. Am Heart J 145 (2003) e1
18. Morrow J.D., Hill K.E., Burk R.F., Nammour K.F., Badr K.F., and Roberts II L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87 (1990) 9383-9387
19. Morrow J.D., Awad J.A., Kato T., et al. Formation of a novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity, an animal model of lipid peroxidation. J Clin Invest 90 (1992) 2502-2507
20. Öhlin H., Pavlidis N., and Ohlin A.K. Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 15;82 12 (1998) 1463-1467
21. Pradelles P., Grassi J., and Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57 7 (1985) 1170-1173
22. CIS Bio International. SHINORIA BNP: directional insert. C. Kitatalogue, May 1998, version 04.
23. Hegbrant J., Thysell H., and Ekman R. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment. Scand J Urol Nephrol 26 2 (1992) 169-176
24. Belch J.J.F., Bridges A., Scott N., and Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 65 (1991) 245-248
25. Nishiyama Y., Ikeda H., Haramaki N., Yoshida N., and Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. Am Heart J 135 1 (1998) 115-120
26. McMurray J., Chopra M., Abdullah I., Smith W.E., and Dargie H.J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14 (1993) 1493-1498
27. Feillet-Coudray C., Chone F., Michel F., et al. Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes. Clin Chim Acta 324 1-2 (2002) 25-30
28. Kukin M.L., Kalman J., Charney R.H., et al. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 99 20 (1999) 2645-2651
29. Lysko P.G., Webb C.L., Gu J.L., Ohlstein E.H., Ruffolor Jr. R.R., and Yue T.L. A comparison of carvedilol and metoprolol antioxidant activities in vitro. J Cardiovasc Pharmacol 36 (2000) 277-281
30. Romero J.C., and Reckelhoff J.F. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34 (1999) 943-949
31. Singh B., and Abraham W.T. Angiotensin-converting enzyme inhibitors and oxidative stress. In: Kukin M.L., and Fuster V. (Eds). Oxidative stress and cardiac failure (2003), Futura Publishing Company, 135 Bedford road, Armonk, NY 10504
32. Jurt U., Gori T., Ravandi A., Babaei S., Zeman P., and Parker J.D. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38 3 (2001) 854-859
33. Keimer R., Stutzer F.K., Tsikas D., Troost R., Gutzki F.M., and Frolich J.C. Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study. J Cardiovasc Pharmacol 41 2 (2003) 284-292
34. Halliwell B., Borish E.T., Pryor W.A., Ames B.N., and Saul R.L. Oxygen free radicals and human disease. Ann Intern Med 107 (1987) 526-545